Scientific Opinion on the substantiation of a health claim related to OPC Premium™ and the reduction of blood cholesterol pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 7, Issue 10, 2009, Pages

[No Author Info available]

Author keywords

berries; blood cholesterol; health claims; oligomeric procyanidins; OPC Premium ; risk reduction

Indexed keywords

EID: 85078381781     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2009.1356     Document Type: Article

References (9)

1. Bagchi D, Bagchi M, Stohs SJ, Das DK, Ray SD, Kuszynski CA, Joshi SS, Pruess HG, 2000. Free radicals and grape seed proantocyanidin extract: importance in human health disease prevention. Toxicology 148, 187–197.
2. Cao G, Booth SLY, Sadowslti JAY, Prior RL, 1998. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am. J. Clin. Nutr. 68, 1081–1087.
3. Daucher L, Amouyel P, Hercberg S, Dallongeville J, 2006. Fruit and Vegetable Consumption and Risk of Coronary Heart Disease: A Meta-Analysis of Cohort Studies. J. Nutr. 136, 2588–2593.
4. Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P, Mattila P, Jula A, 2008. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am. J. Clin. Nutr. 87, 323–331.
5. Hosseini S, Lee J, Sepulveda RT, Rodewald P, Watson RR, 2001. A randomized, double-blind, placebo-controlled, prospective, 16 week crossover study to determine the role of Pycnogenol in modifying blood pressure in mildly hypertensive patients. Nutr. Res. 21, 1251–1260.
6. Natella F, Belelli F, Gentili V, Ursini F, Scaccini C, 2002. Grape seed proanthocyanidins prevent plasma postprandial oxidative stress in humans. J. Agric. Food Chem. 50, 7720–7725.
7. Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J, 2005. Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA 294, 2437–2445.
8. Preuss HG, Wallerstedt D, Talpur N, Tutuncuoglu SO, Echard B, Myers A, Bui M, Bagchi D, 2000. Effects of Niacin-Bound Chromium and Grape Seed Proanthocyanidin Extract on the Lipid Profile of Hypercholesterolemic Subjects: A Pilot study. J. Med. 31, 227–246.
9. WHO (World Health Organization), 2002. World Heart Report - Reducing Risks, Promoting Healthy Life.